Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Background: Trials have addressed the combined use of direct oral anticoagulants (DOACs) and antiplatelets in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI). These trials may have changed prescribing patterns. Methods: This administrative audit of Albertans wit...

Descripció completa

Dades bibliogràfiques
Autors principals:	Theresa E. Eberhardt, PharmD, ACPR, Tammy J. Bungard, BSP, PharmD, Michelle M. Graham, MD, FRCPC, FCCS, Michelle Picard, BScPharm, ACPR, Grace T. Wang, MMath, Margaret L. Ackman, BScPharm, PharmD, ACPR, FCSHP
Format:	Article
Idioma:	English
Publicat:	Elsevier 2022-04-01
Col·lecció:	CJC Open
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2589790X21003565

Ítems similars

Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post–Percutaneous Coronary Intervention
per: Caylie M. Poirier, PharmD, ACPR, et al.
Publicat: (2023-11-01)

Direct Oral Anticoagulant Use Early After Cardiac Surgery: A Retrospective Cohort Study
per: Jung-Jin Wu, PharmD, ACPR, et al.
Publicat: (2024-02-01)

Accuracy of Inpatient Recall of Interaction With a Pharmacist: A Validation Study From 2 Acute Care Teaching Hospitals
per: Vaninder K Sidhu BSc, MSc, BScPharm, ACPR, et al.
Publicat: (2019-03-01)

Comparison of Preventive Cardiovascular Pharmacotherapy in Surgical vs Percutaneous Coronary Revascularization
per: Arden R. Barry, BSc, BSc(Pharm), PharmD, ACPR, et al.
Publicat: (2019-11-01)

The use of concurrent long-acting injectable antipsychotic therapy with paliperidone palmitate and aripiprazole monohydrate in a patient with schizophrenia
per: Christopher Evernden, BSc, BScPharm, ACPR, et al.
Publicat: (2021-09-01)

Decisional Needs and Patient Treatment Preferences for Heart Failure Medications: A Scoping Review
per: Blair J. MacDonald, BA, PharmD, et al.
Publicat: (2023-02-01)

Use of Guideline-Directed Medical Therapy in Patients Aged 80 Years or Older With Heart Failure With Reduced Ejection Fraction
per: Arden R. Barry, BSc, BSc(Pharm), PharmD, ACPR, et al.
Publicat: (2023-04-01)

Managing Heart Failure With Reduced Ejection Fraction in Patients With Chronic Kidney Disease: A Case-Based Approach and Contemporary Review
per: Arden R. Barry, BSc, BSc(Pharm), PharmD, ACPR
Publicat: (2022-09-01)

Severe Hypoglycemia in a Patient With Type 1 Diabetes Mellitus Recently Started on Sacubitril/Valsartan: A Case ReportNovel Teaching Points
per: Arden R. Barry, BSc, BSc(Pharm), PharmD, ACPR
Publicat: (2020-05-01)

The Problem With Predictions: A Cautionary Tale of Empirically Adjusting Apixaban Dosing With CarbamazepineNovel Teaching Points
per: Ayush Chadha, et al.
Publicat: (2022-04-01)

Chronic Amiodarone Use and the Risk of Cancer: A Systematic Review and Meta-analysis
per: Lauren A. Siemers, et al.
Publicat: (2021-01-01)

Clozapine clinical toolkit optimizes inpatient clozapine monitoring
per: Brooke Gessner, PharmD, ACPR, et al.
Publicat: (2024-04-01)

Impact of SGLT2 Inhibitors on Quality of Life in Heart Failure Across the Ejection Fraction Spectrum: Systematic Review and Meta-analysis
per: Yaksh R. Shah, et al.
Publicat: (2024-04-01)

Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with COVID-19: A Multicenter Cohort Study
per: Raed Kensara BSc.Pharm, SCC-CCP, BCPS, et al.
Publicat: (2023-02-01)

Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report
per: Baldwin Kaitlyn PharmD, et al.
Publicat: (2023-10-01)

Heart Failure Management in 2023: A Pharmacotherapy- and Lifestyle-Focused Comparison of Current International Guidelines
per: Blair J. MacDonald, BA, PharmD, et al.
Publicat: (2023-08-01)

Choice of Oral Anticoagulant: Outcomes in Atrial Fibrillation Patients Post-Stroke Despite Direct Oral Anticoagulant Use
per: Eric Duong, BSc, MSc, PharmD, et al.
Publicat: (2023-08-01)

Environmentally sustainable opportunities for health systems: metered-dose inhaler prescribing, dispensing, usage, and waste at The Ottawa Hospital
per: Carolanne Caron, BSc, et al.
Publicat: (2024-04-01)

Opioid toxicity due to CNS depressant polypharmacy: A case report
per: Christine Lee, et al.
Publicat: (2021-03-01)

Carbamazepine Induction Impacting Apixaban Concentrations: A Case ReportNovel Teaching Points
per: Tammy J. Bungard, BSP, PharmD, et al.
Publicat: (2020-09-01)

Community Pharmacy-Based Blood Pressure Screening in Newfoundland and Labrador, Canada for World Hypertension Day 2022: A Cross-Sectional Study
per: Tiffany A. Lee, BSc(Pharm), PharmD, PhD(c), et al.
Publicat: (2024-05-01)

Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease With Recent or Remote Events: Systematic Review and Meta-analysis
per: Ahmad Hayek, MD, et al.
Publicat: (2024-05-01)

Impact of Rounding Checklists on the Outcomes of Patients Admitted to ICUs: A Systematic Review and Meta-Analysis
per: Khrystia M. MacKinnon, BSc, MD, et al.
Publicat: (2024-08-01)

Evaluation of Thrombocytopenia in Patients Receiving Percutaneous Mechanical Circulatory Support With an Impella Device
per: Erin A. Houry, Pharm.D., et al.
Publicat: (2022-10-01)

Evaluation of Online Written Medication Educational Resources for People Living With Heart Failure
per: Simroop Ladhar, BSc, et al.
Publicat: (2022-10-01)

Implementation and evaluation of interprofessional overdose review team recommendations following intentional or accidental overdose events
per: Monica Barrett, PharmD, BCPP, et al.
Publicat: (2024-06-01)

The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study
per: Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM, et al.
Publicat: (2023-12-01)

Knowledge, Attitude and Practice Related to Chemotherapy Among Cancer Patients
per: Muzna Suhail MPhil, et al.
Publicat: (2024-04-01)

Alternatives to Hydrocortisone for Hemodynamic Support in Septic Shock Management Due to Medication Shortage
per: Mohammed Aldhaeefi, PharmD, et al.
Publicat: (2023-07-01)

Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
per: Kim Ehrhard, PharmD, BCPP, et al.
Publicat: (2023-08-01)

Proportion of US Hospitalized Medically Ill Patients Who May Qualify for Extended Thromboprophylaxis
per: Benjamin Miao PharmD, et al.
Publicat: (2019-05-01)

Proposal for an Ambulatory Heart Failure Management Curriculum for Cardiology Residency Training Programs
per: Aws Almufleh, MBBS, MPH, FRCPC, et al.
Publicat: (2022-10-01)

Evaluation of the tacrolimus drug interaction with voriconazole vs clotrimazole in heart transplant recipients
per: Elizabeth Posney, PharmD, et al.
Publicat: (2024-05-01)

Fanconi Syndrome Induced by Concomitant HIV PrEP and Tacrolimus
per: Becky S. Linn PharmD, et al.
Publicat: (2021-10-01)

Adverse childhood experiences among California student pharmacists
per: Shawn R. Smith, PharmD, APh, et al.
Publicat: (2024-02-01)

Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study
per: Khalid Al Sulaiman MBA, BCCCP, BCNSP, FCCM, et al.
Publicat: (2023-06-01)

Assessing intradisciplinary pharmacy communication related to transitions of care
per: Letitia N. Warunek, PharmD, BCPS, et al.
Publicat: (2024-06-01)

Pharmacologic management of adolescent catatonia: A dual-case series
per: Lauren Leiby, PharmD, BCPP, et al.
Publicat: (2024-06-01)

Retrospective Analysis of Medication Adherence and Cost Following Medication Therapy Management
per: Ashley Branham, PharmD, et al.
Publicat: (2010-01-01)

Potential role of a pharmacist to enhance medication-related aspects of clinical trials conducted in a dedicated clinical research unit
per: Kimberly A. Redic, PharmD, et al.
Publicat: (2017-06-01)